Momenta Pharmaceuticals (MNTA) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free MNTA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Momenta Pharmaceuticals Short Interest DataCurrent Short Volume5,410,000 sharesPrevious Short Volume4,400,000 sharesChange Vs. Previous Month+22.95%Dollar Volume Sold Short$283.32 millionShort Interest Ratio / Days to Cover1.7Last Record DateSeptember 15, 2020Outstanding Shares119,029,000 sharesPercentage of Shares Shorted4.55%Today's Trading Volume0 sharesAverage Trading Volume1,939,894 sharesToday's Volume Vs. Average0% Short Selling Momenta Pharmaceuticals ? Sign up to receive the latest short interest report for Momenta Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMNTA Short Interest Over TimeMNTA Days to Cover Over TimeMNTA Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Momenta Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20205,410,000 shares $283.32 million +23.0%N/A1.7 $52.37 8/31/20204,400,000 shares $229.55 million -35.3%N/A1.5 $52.17 8/14/20206,800,000 shares $198.15 million +6.6%N/A2.8 $29.14 7/31/20206,380,000 shares $188.15 million -5.6%N/A5.5 $29.49 7/15/20206,760,000 shares $231.80 million -17.1%N/A6.1 $34.29 6/30/20208,150,000 shares $271.15 million +31.7%N/A7 $33.27 6/15/20206,190,000 shares $220.67 million No ChangeN/A5.5 $35.65 5/29/20206,190,000 shares $194.86 million +51.7%N/A5.7 $31.48 5/15/20204,080,000 shares $126.85 million +15.6%N/A3.5 $31.09 4/30/20203,530,000 shares $111.90 million -12.0%N/A3.1 $31.70 4/15/20204,010,000 shares $106.71 million +12.6%N/A3.5 $26.61 3/31/20203,560,000 shares $96.83 million +4.1%N/A2.7 $27.20 3/13/20203,419,100 shares $97.96 million +2.4%N/A3.1 $28.65 2/28/20203,340,000 shares $94.49 million -10.0%N/A2.5 $28.29 2/14/20203,710,000 shares $118.27 million -10.6%N/A2.9 $31.88 1/31/20204,150,000 shares $120.43 million -20.4%N/A3.5 $29.02 1/15/20205,210,000 shares $150.57 million -7.8%N/A4.6 $28.90 12/31/20195,650,000 shares $111.47 million +19.2%N/A6.2 $19.73 11/29/20194,320,000 shares $72.66 million +2.6%4.4%8 $16.82 MNTA Short Interest - Frequently Asked Questions What is Momenta Pharmaceuticals' current short interest? Short interest is the volume of Momenta Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 5,410,000 shares of MNTA short. Learn More on Momenta Pharmaceuticals' current short interest. What is a good short interest ratio for Momenta Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MNTA shares currently have a short interest ratio of 2.0. Learn More on Momenta Pharmaceuticals's short interest ratio. Is Momenta Pharmaceuticals' short interest increasing or decreasing? Momenta Pharmaceuticals saw a increase in short interest in September. As of September 15th, there was short interest totaling 5,410,000 shares, an increase of 23.0% from the previous total of 4,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Momenta Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Momenta Pharmaceuticals: Exelixis, Inc. (3.01%), Halozyme Therapeutics, Inc. (6.55%), Repligen Co. (8.85%), Neurocrine Biosciences, Inc. (2.03%), Revolution Medicines, Inc. (7.58%), Vaxcyte, Inc. (7.58%), CRISPR Therapeutics AG (17.37%), Krystal Biotech, Inc. (8.59%), Immunovant, Inc. (14.08%), ImmunityBio, Inc. (40.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.24 billion), Aon plc ($3.67 billion), The Clorox Company ($2.89 billion), The Charles Schwab Co. ($2.79 billion), MercadoLibre, Inc. ($2.26 billion), Analog Devices, Inc. ($2.19 billion), Simon Property Group, Inc. ($2.01 billion), The Kroger Co. ($1.94 billion), Moderna, Inc. ($1.89 billion), and International Flavors & Fragrances Inc. ($1.81 billion). View all of the most shorted stocks. What does it mean to sell short Momenta Pharmaceuticals stock? Short selling MNTA is an investing strategy that aims to generate trading profit from Momenta Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Momenta Pharmaceuticals? A short squeeze for Momenta Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MNTA, which in turn drives the price of the stock up even further. How often is Momenta Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MNTA, twice per month. The most recent reporting period available is September, 15 2020. More Short Interest Resources from MarketBeat Related Companies: EXEL Short Squeeze HALO Short Squeeze RGEN Short Squeeze NBIX Short Squeeze RVMD Short Squeeze PCVX Short Squeeze CRSP Short Squeeze KRYS Short Squeeze IMVT Short Squeeze IBRX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MNTA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company